Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Csete

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Chest|April 24, 2021
Stem Cell Therapy for COPD: Hope and ExploitationMarilyn K Glassberg, Isabelle Csete, Emmanuelle Simonet, et al.
Nature Cell Biology|January 10, 2020
TRIP13 regulates DNA repair pathway choice through REV7 conformational changeConnor S Clairmont, Prabha Sarangi, Karthikeyan Ponnienselvan, et al.
Haematologica|August 16, 2019
Mathematical modeling reveals alternative JAK inhibitor treatment in myeloproliferative neoplasmsKaitlyn Shank, Andrew Dunbar, Priya Koppikar, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
<i>TET2</i> and <i>TP53</i> Mutations Cooperatively Modulate the Response to Inflammation to Promote Leukemic TransformationPablo Sánchez Vela, Brianna Kelly, Claudia Brady, et al.
Cancer Discovery|May 31, 2024
CRISPR Dependency Screens in Primary Hematopoietic Stem Cells Identify KDM3B as a Genotype-specific Vulnerability in IDH2- and TET2-mutant CellsMichael R Waarts, Shoron Mowla, Meaghan Boileau, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Chest|April 24, 2021
Stem Cell Therapy for COPD: Hope and ExploitationMarilyn K Glassberg, Isabelle Csete, Emmanuelle Simonet, et al.
Nature Cell Biology|January 10, 2020
TRIP13 regulates DNA repair pathway choice through REV7 conformational changeConnor S Clairmont, Prabha Sarangi, Karthikeyan Ponnienselvan, et al.
Haematologica|August 16, 2019
Mathematical modeling reveals alternative JAK inhibitor treatment in myeloproliferative neoplasmsKaitlyn Shank, Andrew Dunbar, Priya Koppikar, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
<i>TET2</i> and <i>TP53</i> Mutations Cooperatively Modulate the Response to Inflammation to Promote Leukemic TransformationPablo Sánchez Vela, Brianna Kelly, Claudia Brady, et al.
Cancer Discovery|May 31, 2024
CRISPR Dependency Screens in Primary Hematopoietic Stem Cells Identify KDM3B as a Genotype-specific Vulnerability in IDH2- and TET2-mutant CellsMichael R Waarts, Shoron Mowla, Meaghan Boileau, et al.
Pageof 1